-
1
-
-
0031453534
-
AC133, a novel marker for human hematopoietic stem and progenitor cells
-
A.H. Yin, S. Miraglia, E.D. Zanjani, G. Almeida-Porada, M. Ogawa, and A.G. Leary AC133, a novel marker for human hematopoietic stem and progenitor cells Blood 90 1997 5002 5012
-
(1997)
Blood
, vol.90
, pp. 5002-5012
-
-
Yin, A.H.1
Miraglia, S.2
Zanjani, E.D.3
Almeida-Porada, G.4
Ogawa, M.5
Leary, A.G.6
-
2
-
-
77952091738
-
Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation
-
H.S. Hung, W.C. Shyu, C.H. Tsai, S.H. Hsu, S.Z. Lin, and J. Tongers Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation Microvasc Res 79 3 2010 200 206
-
(2010)
Microvasc Res
, vol.79
, Issue.3
, pp. 200-206
-
-
Hung, H.S.1
Shyu, W.C.2
Tsai, C.H.3
Hsu, S.H.4
Lin, S.Z.5
Tongers, J.6
-
3
-
-
74049154827
-
Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases
-
H.S. Hung, W.C. Shyu, C.H. Tsai, S.H. Hsu, and S.Z. Lin Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases Cell Transplant 18 9 2009 1003 1012
-
(2009)
Cell Transplant
, vol.18
, Issue.9
, pp. 1003-1012
-
-
Hung, H.S.1
Shyu, W.C.2
Tsai, C.H.3
Hsu, S.H.4
Lin, S.Z.5
-
4
-
-
79851501898
-
Soluble epoxide hydrolase inhibitors and their potential for treatment of multiple pathologic conditions
-
R.H. Ingraham, R.D. Gless, and H.Y. Lo Soluble epoxide hydrolase inhibitors and their potential for treatment of multiple pathologic conditions Curr Med Chem 18 4 2011 587 603
-
(2011)
Curr Med Chem
, vol.18
, Issue.4
, pp. 587-603
-
-
Ingraham, R.H.1
Gless, R.D.2
Lo, H.Y.3
-
5
-
-
77749279557
-
Soluble epoxide hydrolase inhibition modulates vascular remodeling
-
A.N. Simpkins, R.D. Rudic, S. Roy, H.J. Tsai, B.D. Hammock, and J.D. Imig Soluble epoxide hydrolase inhibition modulates vascular remodeling Am J Physiol Heart Circ Physiol 298 3 2010 H795 H806
-
(2010)
Am J Physiol Heart Circ Physiol
, vol.298
, Issue.3
-
-
Simpkins, A.N.1
Rudic, R.D.2
Roy, S.3
Tsai, H.J.4
Hammock, B.D.5
Imig, J.D.6
-
6
-
-
69849107198
-
Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia
-
L.N. Zhang, J. Vincelette, Y. Cheng, U. Mehra, D. Chen, and S.K. Anandan Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia Arterioscler Thromb Vasc Biol 29 9 2009 1265 1270
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, Issue.9
, pp. 1265-1270
-
-
Zhang, L.N.1
Vincelette, J.2
Cheng, Y.3
Mehra, U.4
Chen, D.5
Anandan, S.K.6
-
7
-
-
0242720683
-
Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function
-
A.A. Spector, X. Fang, G.D. Snyder, and N.L. Weintraub Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function Prog Lipid Res 43 1 2004 55 90
-
(2004)
Prog Lipid Res
, vol.43
, Issue.1
, pp. 55-90
-
-
Spector, A.A.1
Fang, X.2
Snyder, G.D.3
Weintraub, N.L.4
-
8
-
-
0027512995
-
Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase
-
D.C. Zeldin, J. Kobayashi, J.R. Falck, B.S. Winder, B.D. Hammock, and J.R. Snapper Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase J Biol Chem 268 9 1993 Mar 25 6402 6407
-
(1993)
J Biol Chem
, vol.268
, Issue.9
, pp. 6402-6407
-
-
Zeldin, D.C.1
Kobayashi, J.2
Falck, J.R.3
Winder, B.S.4
Hammock, B.D.5
Snapper, J.R.6
-
9
-
-
33947375240
-
Action of epoxyeicosatrienoic acids on cellular function
-
A.A. Spector, and A.W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol 292 3 2007 C996 C1012
-
(2007)
Am J Physiol Cell Physiol
, vol.292
, Issue.3
-
-
Spector, A.A.1
Norris, A.W.2
-
10
-
-
14644429730
-
Epoxide hydrolases: Their roles and interactions with lipid metabolism
-
J.W. Newman, C. Morisseau, and B.D. Hammock Epoxide hydrolases: their roles and interactions with lipid metabolism Prog Lipid Res 44 1 2005 1 51
-
(2005)
Prog Lipid Res
, vol.44
, Issue.1
, pp. 1-51
-
-
Newman, J.W.1
Morisseau, C.2
Hammock, B.D.3
-
11
-
-
0034796332
-
Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance
-
A.W. Miller, C. Dimitropoulou, G. Han, R.E. White, D.W. Busija, and G.O. Carrier Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance Am J Physiol Heart Circ Physiol 281 2001 H1524 H1531
-
(2001)
Am J Physiol Heart Circ Physiol
, vol.281
-
-
Miller, A.W.1
Dimitropoulou, C.2
Han, G.3
White, R.E.4
Busija, D.W.5
Carrier, G.O.6
-
12
-
-
77954902049
-
Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis
-
P. Luo, H.H. Chang, Y. Zhou, S. Zhang, S.H. Hwang, and C. Morisseau Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis J Pharmacol Exp Ther 334 2 2010 430 438
-
(2010)
J Pharmacol Exp Ther
, vol.334
, Issue.2
, pp. 430-438
-
-
Luo, P.1
Chang, H.H.2
Zhou, Y.3
Zhang, S.4
Hwang, S.H.5
Morisseau, C.6
-
13
-
-
79956200976
-
Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?
-
J. Bellien, R. Joannides, V. Richard, and C. Thuillez Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases? Pharmacol Ther 131 1 2011 Jul 1 17
-
(2011)
Pharmacol Ther
, vol.131
, Issue.1
, pp. 1-17
-
-
Bellien, J.1
Joannides, R.2
Richard, V.3
Thuillez, C.4
-
14
-
-
34548755151
-
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
-
N. Chiamvimonvat, C.M. Ho, H.J. Tsai, and B.D. Hammock The soluble epoxide hydrolase as a pharmaceutical target for hypertension J Cardiovasc Pharmacol 50 3 2007 225 237
-
(2007)
J Cardiovasc Pharmacol
, vol.50
, Issue.3
, pp. 225-237
-
-
Chiamvimonvat, N.1
Ho, C.M.2
Tsai, H.J.3
Hammock, B.D.4
-
15
-
-
71449124588
-
Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: High glucose suppresses sEH expression
-
A. Oguro, N. Fujita, and S. Imaoka Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression Drug Metab Pharmacokinet 24 5 2009 438 445
-
(2009)
Drug Metab Pharmacokinet
, vol.24
, Issue.5
, pp. 438-445
-
-
Oguro, A.1
Fujita, N.2
Imaoka, S.3
-
16
-
-
75749084460
-
Inhibition of soluble epoxide hydrolase by trans-4-[4-(3-adamantan-1-yl- ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury
-
K.R. Chaudhary, M. Abukhashim, S.H. Hwang, B.D. Hammock, and J.M. Seubert Inhibition of soluble epoxide hydrolase by trans-4-[4-(3-adamantan-1-yl-ureido) -cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury J Cardiovasc Pharmacol 55 1 2010 67 73
-
(2010)
J Cardiovasc Pharmacol
, vol.55
, Issue.1
, pp. 67-73
-
-
Chaudhary, K.R.1
Abukhashim, M.2
Hwang, S.H.3
Hammock, B.D.4
Seubert, J.M.5
-
17
-
-
79251513275
-
Soluble epoxide hydrolase inhibitors and heart failure
-
H. Qiu, N. Li, J.Y. Liu, T.R. Harris, B.D. Hammock, and N. Chiamvimonvat Soluble epoxide hydrolase inhibitors and heart failure Cardiovasc Ther 2010 23
-
(2010)
Cardiovasc Ther
, pp. 23
-
-
Qiu, H.1
Li, N.2
Liu, J.Y.3
Harris, T.R.4
Hammock, B.D.5
Chiamvimonvat, N.6
-
18
-
-
33845474465
-
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
-
D. Xu, N. Li, Y. He, V. Timofeyev, L. Lu, and H.J. Tsai Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors Proc Natl Acad Sci U S A 103 49 2006 18733 18738
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, Issue.49
, pp. 18733-18738
-
-
Xu, D.1
Li, N.2
He, Y.3
Timofeyev, V.4
Lu, L.5
Tsai, H.J.6
-
19
-
-
70349636047
-
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
-
J.D. Imig, and B.D. Hammock Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Nat Rev Drug Discov 8 10 2009 794 805
-
(2009)
Nat Rev Drug Discov
, vol.8
, Issue.10
, pp. 794-805
-
-
Imig, J.D.1
Hammock, B.D.2
-
20
-
-
70350604449
-
Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches
-
N. Li, J.Y. Liu, V. Timofeyev, H. Qiu, S.H. Hwang, and D. Tuteja Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches J Mol Cell Cardiol 47 6 2009 835 845
-
(2009)
J Mol Cell Cardiol
, vol.47
, Issue.6
, pp. 835-845
-
-
Li, N.1
Liu, J.Y.2
Timofeyev, V.3
Qiu, H.4
Hwang, S.H.5
Tuteja, D.6
-
21
-
-
34548070313
-
Orally bioavailable potent soluble epoxide hydrolase inhibitors
-
S.H. Hwang, H.J. Tsai, J.Y. Liu, C. Morisseau, and B.D. Hammock Orally bioavailable potent soluble epoxide hydrolase inhibitors J Med Chem 50 16 2007 3825 3840
-
(2007)
J Med Chem
, vol.50
, Issue.16
, pp. 3825-3840
-
-
Hwang, S.H.1
Tsai, H.J.2
Liu, J.Y.3
Morisseau, C.4
Hammock, B.D.5
-
22
-
-
54049094100
-
Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion
-
M.R. Schroeter, M. Leifheit, P. Sudholt, N.M. Heida, C. Dellas, and I. Rohm Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion Circ Res 103 5 2008 536 544
-
(2008)
Circ Res
, vol.103
, Issue.5
, pp. 536-544
-
-
Schroeter, M.R.1
Leifheit, M.2
Sudholt, P.3
Heida, N.M.4
Dellas, C.5
Rohm, I.6
-
23
-
-
34248210174
-
A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart
-
C. Qian, R.A. Tio, A.J. Roks, K.M. Boddeus, M.C. Harmsen, and W.H. van Gilst A promising technique for transplantation of bone marrow-derived endothelial progenitor cells into rat heart Cardiovasc Pathol 16 3 2007 May-Jun 127 135
-
(2007)
Cardiovasc Pathol
, vol.16
, Issue.3
, pp. 127-135
-
-
Qian, C.1
Tio, R.A.2
Roks, A.J.3
Boddeus, K.M.4
Harmsen, M.C.5
Van Gilst, W.H.6
-
24
-
-
0038376000
-
Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
-
S. Rafii, and D. Lyden Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat Med 9 6 2003 Jun 702 712
-
(2003)
Nat Med
, vol.9
, Issue.6
, pp. 702-712
-
-
Rafii, S.1
Lyden, D.2
-
25
-
-
0034908652
-
MG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
-
S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, and M. Tiemann MG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J Clin Invest 108 3 2001 Aug 391 397
-
(2001)
J Clin Invest
, vol.108
, Issue.3
, pp. 391-397
-
-
Dimmeler, S.1
Aicher, A.2
Vasa, M.3
Mildner-Rihm, C.4
Adler, K.5
Tiemann, M.6
-
26
-
-
28044434102
-
The antiinflammatory effect of laminar flow: The role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase
-
Y. Liu, Y. Zhang, K. Schmelzer, T.S. Lee, X. Fang, and Y. Zhu The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase Proc Natl Acad Sci U S A 102 46 2005 16747 16752
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, Issue.46
, pp. 16747-16752
-
-
Liu, Y.1
Zhang, Y.2
Schmelzer, K.3
Lee, T.S.4
Fang, X.5
Zhu, Y.6
-
27
-
-
33644811595
-
Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor
-
M. Lee, M. Aoki, T. Kondo, K. Kobayashi, K. Okumura, and K. Komori Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor Arterioscler Thromb Vasc Biol 25 12 2005 Dec 2535 2541
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, Issue.12
, pp. 2535-2541
-
-
Lee, M.1
Aoki, M.2
Kondo, T.3
Kobayashi, K.4
Okumura, K.5
Komori, K.6
-
28
-
-
0037167646
-
Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis
-
M.C. Cid, J. Hernández-Rodríguez, M.J. Esteban, M. Cebrián, Y.S. Gho, and C. Font Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis Circulation 106 13 2002 Sep 24 1664 1671
-
(2002)
Circulation
, vol.106
, Issue.13
, pp. 1664-1671
-
-
Cid, M.C.1
Hernández-Rodríguez, J.2
Esteban, M.J.3
Cebrián, M.4
Gho, Y.S.5
Font, C.6
-
29
-
-
54149095036
-
Endothelial progenitor cells in neovascularization of infarcted myocardium
-
K. Jujo, M. Ii, and D.W. Losordo Endothelial progenitor cells in neovascularization of infarcted myocardium J Mol Cell Cardiol 45 4 2008 530 544
-
(2008)
J Mol Cell Cardiol
, vol.45
, Issue.4
, pp. 530-544
-
-
Jujo, K.1
Ii, M.2
Losordo, D.W.3
-
30
-
-
77950645164
-
Pharmacologic targeting of endothelial progenitor cells [J]
-
M. Albiero, L. Menegazzo, A. Avogaro, and G.P. Fadini Pharmacologic targeting of endothelial progenitor cells [J] Cardiovasc Hematol Disord Drug Targets 10 1 2010 16 32
-
(2010)
Cardiovasc Hematol Disord Drug Targets
, vol.10
, Issue.1
, pp. 16-32
-
-
Albiero, M.1
Menegazzo, L.2
Avogaro, A.3
Fadini, G.P.4
-
31
-
-
24344442873
-
Circulating endothelial progenitor cells and cardiovascular outcomes
-
N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, and A. Link Circulating endothelial progenitor cells and cardiovascular outcomes N Engl J Med 353 10 2005 Sep 8 999 1007
-
(2005)
N Engl J Med
, vol.353
, Issue.10
, pp. 999-1007
-
-
Werner, N.1
Kosiol, S.2
Schiegl, T.3
Ahlers, P.4
Walenta, K.5
Link, A.6
-
32
-
-
77952090934
-
EPCs and pathological angiogenesis: When good cells go bad
-
S. Li Calzi, M.B. Neu, L.C. Shaw, J.L. Kielczewski, N.I. Moldovan, and M.B. Grant EPCs and pathological angiogenesis: when good cells go bad Microvasc Res 79 3 2010 207 216
-
(2010)
Microvasc Res
, vol.79
, Issue.3
, pp. 207-216
-
-
Li Calzi, S.1
Neu, M.B.2
Shaw, L.C.3
Kielczewski, J.L.4
Moldovan, N.I.5
Grant, M.B.6
-
33
-
-
53249091923
-
Endothelial progenitor cells in vascular repair and remodeling
-
M. Hristov, and C. Weber Endothelial progenitor cells in vascular repair and remodeling Pharmacol Res 58 2 2008 148 151
-
(2008)
Pharmacol Res
, vol.58
, Issue.2
, pp. 148-151
-
-
Hristov, M.1
Weber, C.2
-
34
-
-
44449109955
-
Vascular repair by endothelial progenitor cells
-
A. Zampetaki, J.P. Kirton, and Q. Xu Vascular repair by endothelial progenitor cells Cardiovasc Res 78 3 2008 413 421
-
(2008)
Cardiovasc Res
, vol.78
, Issue.3
, pp. 413-421
-
-
Zampetaki, A.1
Kirton, J.P.2
Xu, Q.3
-
35
-
-
0034988491
-
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
-
K.A. Jackson, S.M. Majka, H. Wang, J. Pocius, C.J. Hartley, and M.W. Majesky Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells J Clin Invest 107 2001 1395 1402
-
(2001)
J Clin Invest
, vol.107
, pp. 1395-1402
-
-
Jackson, K.A.1
Majka, S.M.2
Wang, H.3
Pocius, J.4
Hartley, C.J.5
Majesky, M.W.6
-
36
-
-
0035793330
-
Vascular trauma induces rapid but transient mobilization of VEGFR2 + AC331 + endothelial precursor cells
-
M. Gill, S. Dias, K. Hattori, M.L. Rivera, D. Hicklin, and L. Witte Vascular trauma induces rapid but transient mobilization of VEGFR2 + AC331 + endothelial precursor cells Circ Res 88 2001 167 174
-
(2001)
Circ Res
, vol.88
, pp. 167-174
-
-
Gill, M.1
Dias, S.2
Hattori, K.3
Rivera, M.L.4
Hicklin, D.5
Witte, L.6
-
37
-
-
0035849588
-
Mobilization of endothelial progenitor cells in patients with acute myocardial infarction
-
S. Shintani, T. Murohara, H. Ikeda, T. Ueno, T. Honma, and A. Katoh Mobilization of endothelial progenitor cells in patients with acute myocardial infarction Circulation 103 2001 2776 2779
-
(2001)
Circulation
, vol.103
, pp. 2776-2779
-
-
Shintani, S.1
Murohara, T.2
Ikeda, H.3
Ueno, T.4
Honma, T.5
Katoh, A.6
-
38
-
-
8744262864
-
Mobilization of CD34/CXCR4+, CD34/CD117+, c-met + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction
-
W. Wojakowiski, M. Tendera, A. Michalowska, M. Majka, M. Kucia, and K. Maslsnkiewicz Mobilization of CD34/CXCR4+, CD34/CD117+, c-met + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction Circulation 110 2004 3213 3220
-
(2004)
Circulation
, vol.110
, pp. 3213-3220
-
-
Wojakowiski, W.1
Tendera, M.2
Michalowska, A.3
Majka, M.4
Kucia, M.5
Maslsnkiewicz, K.6
-
39
-
-
19944427179
-
Increased circulating hematopoietic and endothelial progenitorcells in the early phase of acute myocardial infarction
-
M. Massa, V. Rosti, M. Ferrario, R. Campanelli, I. Ramajoli, and R. Rosso Increased circulating hematopoietic and endothelial progenitorcells in the early phase of acute myocardial infarction Blood 105 2005 199 206
-
(2005)
Blood
, vol.105
, pp. 199-206
-
-
Massa, M.1
Rosti, V.2
Ferrario, M.3
Campanelli, R.4
Ramajoli, I.5
Rosso, R.6
-
40
-
-
39149117997
-
Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease
-
A. Liguori, C. Fiorito, M.L. Balestrieri, E. Crimi, G. Bruzzese, and S. Williams-Ignarro Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease Eur J Haematol 80 3 2008 258 264
-
(2008)
Eur J Haematol
, vol.80
, Issue.3
, pp. 258-264
-
-
Liguori, A.1
Fiorito, C.2
Balestrieri, M.L.3
Crimi, E.4
Bruzzese, G.5
Williams-Ignarro, S.6
-
41
-
-
77953493752
-
Correlations between progression of coronary artery disease and circulating endothelial progenitor cells
-
C. Briguori, U. Testa, R. Riccioni, A. Colombo, E. Petrucci, and G. Condorelli Correlations between progression of coronary artery disease and circulating endothelial progenitor cells FASEB J 24 6 2010 1981 1988
-
(2010)
FASEB J
, vol.24
, Issue.6
, pp. 1981-1988
-
-
Briguori, C.1
Testa, U.2
Riccioni, R.3
Colombo, A.4
Petrucci, E.5
Condorelli, G.6
-
42
-
-
17644433975
-
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
-
M. Vasa, S. Fichtlscherer, A. Aicher, K. Adler, C. Urbich, and H. Martin Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ Res 89 1 2001 Jul 6 E1 E7
-
(2001)
Circ Res
, vol.89
, Issue.1
-
-
Vasa, M.1
Fichtlscherer, S.2
Aicher, A.3
Adler, K.4
Urbich, C.5
Martin, H.6
-
43
-
-
67649880261
-
Role of stromal cell-derived factor-1alpha, level and value of circulating interleukin-10 and endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty
-
L.T. Chang, C.M. Yuen, C.K. Sun, C.J. Wu, J.J. Sheu, and S. Chua Role of stromal cell-derived factor-1alpha, level and value of circulating interleukin-10 and endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty Circ J 73 6 2009 Jun 1097 1104
-
(2009)
Circ J
, vol.73
, Issue.6
, pp. 1097-1104
-
-
Chang, L.T.1
Yuen, C.M.2
Sun, C.K.3
Wu, C.J.4
Sheu, J.J.5
Chua, S.6
-
44
-
-
84865534163
-
Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: A randomized, controlled trial
-
C. Baran, S. Durdu, K. Dalva, C. Zaim, A. Dogan, and G. Ocakoglu Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial Stem Cell Rev 8 3 2012 Sept 963 971
-
(2012)
Stem Cell Rev
, vol.8
, Issue.3
, pp. 963-971
-
-
Baran, C.1
Durdu, S.2
Dalva, K.3
Zaim, C.4
Dogan, A.5
Ocakoglu, G.6
-
45
-
-
77957296671
-
Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: In vivo and in vitro studies
-
H.W. Chang, S. Leu, C.K. Sun, C.L. Hang, A.A. Youssef, and Y.K. Hsieh Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies Transl Res 156 4 2010 Oct 251 263
-
(2010)
Transl Res
, vol.156
, Issue.4
, pp. 251-263
-
-
Chang, H.W.1
Leu, S.2
Sun, C.K.3
Hang, C.L.4
Youssef, A.A.5
Hsieh, Y.K.6
-
46
-
-
3142750485
-
Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease
-
T.Q. Min, C.J. Zhu, W.X. Xiang, Z.J. Hui, and S.Y. Peng Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease Cardiovasc Drugs Ther 18 3 2004 May 203 209
-
(2004)
Cardiovasc Drugs Ther
, vol.18
, Issue.3
, pp. 203-209
-
-
Min, T.Q.1
Zhu, C.J.2
Xiang, W.X.3
Hui, Z.J.4
Peng, S.Y.5
-
47
-
-
84858698955
-
Nifedipine ameliorates ischemia-induced revascularization in diet-induced obese mice
-
T. Kito, R. Shibata, M. Kondo, T. Yamamoto, H. Suzuki, and M. Ishii Nifedipine ameliorates ischemia-induced revascularization in diet-induced obese mice Am J Hypertens 25 4 2012 Apr 401 406
-
(2012)
Am J Hypertens
, vol.25
, Issue.4
, pp. 401-406
-
-
Kito, T.1
Shibata, R.2
Kondo, M.3
Yamamoto, T.4
Suzuki, H.5
Ishii, M.6
-
48
-
-
81055140207
-
Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice
-
L. Dong, L. Kang, L. Ding, Q. Chen, J. Bai, and R. Gu Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice Microvasc Res 82 3 2011 Nov 227 236
-
(2011)
Microvasc Res
, vol.82
, Issue.3
, pp. 227-236
-
-
Dong, L.1
Kang, L.2
Ding, L.3
Chen, Q.4
Bai, J.5
Gu, R.6
-
49
-
-
42049108166
-
Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood
-
J. Smythe, A. Fox, N. Fisher, E. Frith, A.L. Harris, and S.M. Watt Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood Tissue Eng Part C Methods 14 1 2008 59 67
-
(2008)
Tissue Eng Part C Methods
, vol.14
, Issue.1
, pp. 59-67
-
-
Smythe, J.1
Fox, A.2
Fisher, N.3
Frith, E.4
Harris, A.L.5
Watt, S.M.6
-
50
-
-
21744461723
-
Therapeutic potential of endothelial progenitor cells in cardiovascular diseases
-
V.J. Dzau, M. Gnecchi, A.S. Pachori, F. Morello, and L.G. Melo Therapeutic potential of endothelial progenitor cells in cardiovascular diseases Hypertension 46 1 2005 Jul 7 18
-
(2005)
Hypertension
, vol.46
, Issue.1
, pp. 7-18
-
-
Dzau, V.J.1
Gnecchi, M.2
Pachori, A.S.3
Morello, F.4
Melo, L.G.5
-
51
-
-
2942572769
-
Therapeutic angiogenesis and vasculogenesis for ischemic disease: Part II: Cell-based therapies
-
D.W. Losordo, and S. Dimmeler Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies Circulation 109 22 2004 Jun 8 2692 2697
-
(2004)
Circulation
, vol.109
, Issue.22
, pp. 2692-2697
-
-
Losordo, D.W.1
Dimmeler, S.2
-
52
-
-
79952199070
-
Systems biology of pro-angiogenic therapies targeting the VEGF system
-
F. Mac Gabhann, A.A. Qutub, B.H. Annex, and A.S. Popel Systems biology of pro-angiogenic therapies targeting the VEGF system Wiley Interdiscip Rev Syst Biol Med 2 6 2010 Nov-Dec 694 707
-
(2010)
Wiley Interdiscip Rev Syst Biol Med
, vol.2
, Issue.6
, pp. 694-707
-
-
Mac Gabhann, F.1
Qutub, A.A.2
Annex, B.H.3
Popel, A.S.4
-
53
-
-
68849128804
-
Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization
-
J.X. Yu, X.F. Huang, W.M. Lv, C.S. Ye, X.Z. Peng, and H. Zhang Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization J Vasc Surg 50 3 2009 608 616
-
(2009)
J Vasc Surg
, vol.50
, Issue.3
, pp. 608-616
-
-
Yu, J.X.1
Huang, X.F.2
Lv, W.M.3
Ye, C.S.4
Peng, X.Z.5
Zhang, H.6
-
54
-
-
38149035012
-
Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs
-
M. Jiang, B. Wang, C. Wang, B. He, H. Fan, and T.B. Guo Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs J Cell Biochem 103 1 2008 321 334
-
(2008)
J Cell Biochem
, vol.103
, Issue.1
, pp. 321-334
-
-
Jiang, M.1
Wang, B.2
Wang, C.3
He, B.4
Fan, H.5
Guo, T.B.6
-
55
-
-
44949206575
-
Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: A unifying hypothesis
-
M.R. Hoenig, C. Bianchi, and F.W. Sellke Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis Curr Drug Targets 9 5 2008 422 435
-
(2008)
Curr Drug Targets
, vol.9
, Issue.5
, pp. 422-435
-
-
Hoenig, M.R.1
Bianchi, C.2
Sellke, F.W.3
-
56
-
-
77951884617
-
Review article: Epoxyeicosatrienoic acids: Novel mediators of cardioprotection
-
K. Nithipatikom, and G.J. Gross Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection J Cardiovasc Pharmacol Ther 15 2 2010 112 119
-
(2010)
J Cardiovasc Pharmacol Ther
, vol.15
, Issue.2
, pp. 112-119
-
-
Nithipatikom, K.1
Gross, G.J.2
-
57
-
-
66349109660
-
Arachidonic acid cytochrome P450 epoxygenase pathway
-
A.A. Spector Arachidonic acid cytochrome P450 epoxygenase pathway J Lipid Res 50 Suppl. 2009 S52 S56
-
(2009)
J Lipid Res
, vol.50
, Issue.SUPPL.
-
-
Spector, A.A.1
-
58
-
-
57349126277
-
Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis
-
A.C. Webler, U.R. Michaelis, R. Popp, E. Barbosa-Sicard, A. Murugan, and J.R. Falck Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis Am J Physiol Cell Physiol 295 5 2008 C1292 C1301
-
(2008)
Am J Physiol Cell Physiol
, vol.295
, Issue.5
-
-
Webler, A.C.1
Michaelis, U.R.2
Popp, R.3
Barbosa-Sicard, E.4
Murugan, A.5
Falck, J.R.6
-
59
-
-
84860185460
-
Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects
-
D. Chen, R. Whitcomb, E. Macintyre, V. Tran, Z.N. Do, and J. Sabry Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects J Clin Pharmacol 52 3 2012 Mar 319 328
-
(2012)
J Clin Pharmacol
, vol.52
, Issue.3
, pp. 319-328
-
-
Chen, D.1
Whitcomb, R.2
MacIntyre, E.3
Tran, V.4
Do, Z.N.5
Sabry, J.6
|